Wednesday, February 22, 2012 2:30:53 PM
Just FYSA (for your special advisement). SS1
Atrinsic Inc. (OTC:ATRN) continues to trade in a range as the stock looks for any direction. Down 10% today, ATRN continues to be pushed by message boards and other online forums. The company has been quiet on the news front. Volume continues to eclipse its 3-month average. For all but the most risk-tolerant traders, this is one you definitely watch from the sidelines, regardless of what the message boards say.
Retrieved on 22 Feb 2012 from http://www.active-investor.com/4-hot-penny-stocks-dominating-the-market-nsrs-atrn-hral-attd-3997
Recent PTIX News
- Protagenic Therapeutics Completes Phytanix Separation, Strengthens Balance Sheet and Repositions the Company Around PT00114 • ACCESS Newswire • 03/17/2026 12:00:00 PM
- Protagenic Therapeutics Upgrades from OTC Pink to OTCQB Venture Market • ACCESS Newswire • 03/10/2026 12:00:00 PM
- Results from Phase 1 Multiple-Dose Study of PT00114 • ACCESS Newswire • 12/09/2025 01:46:00 PM
- Protagenic Therapeutics Announces Receipt of Nasdaq Non-Compliance Notice • ACCESS Newswire • 11/27/2025 08:45:00 AM
- Protagenic Therapeutics Announces Completion of Enrollment and Dosing in Phase 1 MAD Study • ACCESS Newswire • 11/13/2025 01:22:00 PM
- Protagenic Therapeutics Announces Grant of new patent in Japan for its Modified Stilbenoid Program Drug Candidates • GlobeNewswire Inc. • 07/30/2025 12:30:00 PM
- Nasdaq Top 5 Premarket Losers • IH Market News • 05/20/2025 12:47:37 PM
- Protagenic Therapeutics Soars 190% on Merger to Launch Neuroactive Biopharma Firm • IH Market News • 05/19/2025 02:28:09 PM
- Nasdaq Top 5 Premarket Gainers • IH Market News • 05/19/2025 01:07:08 PM
